Status:
COMPLETED
Ethyl-EPA Treatment of Prodromal Patients
Lead Sponsor:
Yale University
Conditions:
Schizophrenia Prodrome
Eligibility:
All Genders
14-35 years
Phase:
PHASE2
PHASE3
Brief Summary
This is an open-label trial of an omega-3 fatty acid for symptoms of the schizophrenia prodrome.
Eligibility Criteria
Inclusion
- meets criteria for schizophrenia prodrome
Exclusion
- any lifetime antipsychotic treatment
Key Trial Info
Start Date :
September 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2005
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00634361
Start Date
September 1 2001
End Date
August 1 2005
Last Update
May 22 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.